Barry J. Regan - 29 Mar 2022 Form 4 Insider Report for DEXCOM INC (DXCM)

Role: EVP Global Operations
Signature: By: Jereme Sylvain For: Barry J Regan
Issuer symbol: DXCM
Transactions as of: 29 Mar 2022
Transactions value $: -$553,000
Form type: 4
Filing time: 30 Mar 2022, 17:49:52 UTC
Previous filing: 10 Mar 2022
Next filing: 22 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DXCM	Common Stock	Sale	-$553K	-1.11K	-6.34%	$500.00	16.3K	29 Mar 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 14, 2021, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2	Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024.

Content

On September 14, 2021, Mr. Regan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Regan. The shares set forth above were sold pursuant to the 10b5-1 Plan.

Included in this number are 16,345 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,671 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 6,156 of which were granted on November 19, 2020 and shall vest through November 19, 2024.